Putting Carevive SMART Data to Work

Carevive SMART Data is making waves in the pharmaceutical industry as it gets licensed to companies looking to enhance their value chain. This revolutionary dataset is being utilized for crucial use cases, particularly in clinical trials.

Pharmaceutical companies are now leveraging SMART Data to precisely target the right patient populations and determine essential patient experience measures for inclusion in their clinical trials. By integrating this definitive set of Patient-Reported Outcomes (PROs) into new study designs, trials gain a valuable dimension that bolsters the quality of trial data and strengthens regulatory submissions.

We’re excited to discuss Carevive SMART Data with you in-depth, showcasing how it can transform your clinical trials and regulatory strategies. Together, let’s pave the way for more effective and patient-centered therapies in the ever-evolving landscape of cancer care.

Recent Episodes

Emergency departments across the U.S. are under unprecedented strain, with overcrowding, staffing shortages, and inpatient bed constraints converging into a throughput crisis. The American Hospital Association reports that hospital capacity and workforce growth have lagged, intensifying delays from arrival to disposition. At the same time, advances in artificial intelligence are moving from experimental to operational—raising…

Episode 4 of The Future of Patient Monitoring takes a step back from infrastructure and innovation to explore something deeper: the people behind the technology—and what they’ve learned through years of building smarter systems. Part of the Health and Life Sciences at the Edge podcast series, this conversation is led by Intel’s Kaeli Tully,…

As hospitals across the U.S. shorten length of stay and push more recovery into the home, families are increasingly left to manage complex care needs without formal training or support. Roughly one in five patients with chronic conditions like COPD or congestive heart failure is readmitted within 30 days—a cycle that costs the healthcare…